MDS Non-Motor Symptoms - Questionnaire (MDS-NMS-Q)
Permission is required for each single use of the MDS Clinical Outcome Assessments.
The MDS-NMS-Q is a self-completed, simplified (focusing on severity only) questionnaire version of the rater-administered MDS-NMS, developed and validated for use in Parkinson’s disease (PD).
The main instrument of the MDS-NMS-Q is a 13-domain, 52-item instrument covering the most commonly-reported non-motor symptoms in Parkinson’s disease. There is also a separate, non-motor fluctuations (NMFs) subscale covering 8 commonly-reported NMFs occurring in the context of PD medication wearing “off” periods. In the validation study, data quality was satisfactory for all 13 MDS-NMS-Q domains. There were no floor or ceiling effects for the total score; individual domains had no appreciable ceiling effects but variable floor effects. Internal consistency for most domains was satisfactory, except for the impulse control domain. Correlation and concordance between MDS-NMS-Q and MDS-NMS total scores were high. Thus, the MDS-NMS-Q has a strong association and concordance with the MDS-NMS at the total score and domain level. This indicates that the MDS-NMS-Q, allowing self-completion and focusing only on symptom severity, is an acceptable alternative to the rater- administered MDS-NMS.
Authors: K. Ray Chaudhuri, Anette Schrag, Daniel Weintraub, Alexandra Rizos, Pablo Martinez-Martin
- Acronym: MDS-NMS-Q
- Year Published: 2021
- Scale Last Updated: No updates since publication
- Estimated Time to Complete: 10 minutes
- Assessment Type: PRO
- Available translations: None
To request permission to use this Rating Scale, please fill out a Permission Request Form.
Additional Scale Publications
Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)
D. Weintraub, KR. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, J. Gallagher, J. Staunton, M. Pereira Fernandes, C. Rodriguez Blazquez
October 2024
Movement Disorders 2024; 39 (suppl 1). Abstract 323.